Functional Genome Mining Reveals a Class V Lanthipeptide Containing a D‐amino Acid Introduced by an F420H2‐Dependent Reductase

Min Xu,Fei Zhang,Zhuo Cheng,Ghader Bashiri,Jing Wang,Jiali Hong,Yemin Wang,Lijun Xu,Xuefei Chen,Sheng-Xiong Huang,Shuangjun Lin,Zixin Deng,Meifeng Tao
DOI: https://doi.org/10.1002/anie.202008035
2020-01-01
Angewandte Chemie
Abstract:Lantibiotics are a type of ribosomally synthesized and post-translationally modified peptides (termed lanthipeptides) with often potent antimicrobial activity. Herein, we report the discovery of a new lantibiotic, lexapeptide, using the library expression analysis system (LEXAS) approach. Lexapeptide has rare structural modifications, including N-terminal (N,N)-dimethyl phenylalanine, C-terminal (2-aminovinyl)-3-methyl-cysteine, and d-Ala. The characteristic lanthionine moiety in lexapeptide is formed by three proteins (LxmK, LxmX, and LxmY), which are distinct from enzymes known to be involved in lanthipeptide biosynthesis. Furthermore, a novel F420 H2 -dependent reductase (LxmJ) from the lexapeptide biosynthetic gene cluster (BGC) is identified to catalyze the reduction of dehydroalanine to install d-Ala. Our findings suggest that lexapeptide is the founding member of a new class of lanthipeptides that we designate as class V. We also identified further class V lanthipeptide BGCs in actinomycetes and cyanobacteria genomes, implying that other class V lantibiotics await discovery.
What problem does this paper attempt to address?